Significant Agreements and Contracts - Acquisition of Virex Health, Inc. - Additional Information (Details) - Virex Health, Inc [Member] - USD ($)		9 Months Ended
	Feb. 01, 2022	Sep. 30, 2022
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Business acquisition, effective date of acquisition		Feb. 01, 2022
Business acquisition, name of acquired entity		Virex Health, Inc.
Consideration transferred amount	$ 11,400,000
Business acquisition consideration paid in cash	6,800,000
Transaction cost paid	$ 100,000
Number of common stock issued under purchase consideration	1,281,662
Business combination consideration share price	$ 4,500,000
Business combination contingent consideration regulatory payments	10,000,000.0
Contingent consideration, liability		$ 0
Consideration transferred net of short-term liabilities assumed	$ 11,700,000